Dr. Christopher R. Heery, M.D. to the position of Chief Medical Officer. In this role, Dr. Heery will oversee preclinical and clinical development of the Company’s infectious disease and immuno-oncology portfolio. He will report to Paul Chaplin, CEO, and will be based on the east coast of the United States.
Most recently, Dr. Heery was Director of the Clinical Trials Group of the Laboratory of Tumor Immunology and Biology at the National Cancer Institute (NCI). He joined the NCI Medical Oncology Branch as a Medical Oncology Fellow in 2009 and also served as an Adjunct Appointment in the Genitourinary Malignancies Branch. He was also part of the larger effort of the Laboratory of Tumor Immunology and Biology to create new immunotherapies for the treatment of cancer.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)